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The transcription factor Sox2 maintains the pluripo-
tency of early embryonic cells and regulates the
formation of several epithelia during fetal develop-
ment. Whether Sox2 continues to play a role in adult
tissues remains largely unknown. We show here that
Sox2 marks adult cells in several epithelial tissues
where its expression has not previously been charac-
terized, including the stomach, cervix, anus, testes,
lens, and multiple glands. Genetic lineage tracing
and transplantation experiments demonstrate that
Sox2-expressing cells continuously give rise to
mature cell types within these tissues, documenting
their self-renewal and differentiation potentials. Con-
sistent with these findings, ablation of Sox2+ cells in
mice results in a disruption of epithelial tissue ho-
meostasis and lethality. Developmental fatemapping
reveals that Sox2+ adult stem cells originate from
fetal Sox2+ tissue progenitors. Thus, our results iden-
tify Sox2 expression in numerous adult endodermal
and ectodermal stem cell compartments, which are
critical for normal tissue regeneration and survival.
INTRODUCTION
It remains an unresolved question whether the self-renewal of
pluripotent, fetal, and adult stem cells is controlled by the
same or by different molecules. Recent findings show that
expression of the polycomb group protein Bmi-1 (Sangiorgi
and Capecchi, 2008, 2009), the HMG box transcription factor
Sox9 (Furuyama et al., 2011), the telomere subunit Tert (Breault
et al., 2008; Montgomery et al., 2011), and the G-protein-
coupled receptor Lgr5 (Barker et al., 2007, 2010b; Jaks et al.,
2008) mark various types of adult stem cells. While these obser-Cvations indicate molecular commonalities among different
somatic stem cells, these regulators are mostly absent in plurip-
otent stem cells. Another previous study documented that
depletion of the zinc finger transcription factor Zfx1 (Galan-Car-
idad et al., 2007) affects the self-renewal of both embryonic stem
cells (ESCs) and hematopoietic stem cells, suggesting common
mechanisms between pluripotent stem cells and this meso-
dermal stem cell type. However, Zfx1 is also expressed in differ-
entiated cells and its role in endodermal and ectodermal stem
cell compartments has not yet been described. Lastly, several
reports have claimed that the pluripotency genes Oct4 and
Nanog are expressed in adult stem cells, but analyses of reporter
animals and genetic knockout studies failed to confirm these
findings (Lengner et al., 2007). In contrast, accumulating
evidence suggests that Sox2, which maintains pluripotency in
concert with Oct4 and Nanog, may play additional roles in fetal
and adult progenitors.
Sox2 belongs to a large family of SRY-related HMG box tran-
scription factors that are important during development and
cellular differentiation (Lefebvre et al., 2007). Sox2 is initially ex-
pressed in the inner cell mass (ICM) and extraembryonic ecto-
derm of blastocysts (Avilion et al., 2003). Embryos deficient for
Sox2 lack a pluripotent ICM and fail early in development, while
deletion of Sox2 in ESCs results in their inappropriate differenti-
ation into trophectoderm-like cells (Masui et al., 2007). Forced
expression of Sox2, in combination with Oct4, Klf4, and c-Myc,
endows somatic cells with pluripotency, giving rise to induced
pluripotent stem cells (Takahashi and Yamanaka, 2006). Collec-
tively, these results underline the importance of Sox2 in both the
establishment and maintenance of pluripotent stem cells.
Upon exit from pluripotency, Sox2 signaling is critical for the
formation of several endodermal and ectodermal tissues during
fetal development, including the nervous system (Bylund et al.,
2003; Ellis et al., 2004; Graham et al., 2003), lens epithelium
(Kamachi et al., 1998), anterior foregut endoderm (Que et al.,
2007), and its derivatives, as well as sensory cells of the taste
bud (Okubo et al., 2006), inner ear (Kiernan et al., 2005), and
retina (Mansukhani et al., 2005; Taranova et al., 2006). Moreell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc. 317
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tissues, such as progenitors of the brain (Brazel et al., 2005; Ellis
et al., 2004) and retina (Taranova et al., 2006), trachea (Que et al.,
2009), tongue epithelium (Okubo et al., 2009), and dermal papilla
of the hair follicle (Driskell et al., 2009), aswell as putative progen-
itors of pituitary gland (Fauquier et al., 2008). Importantly, a
systematic survey of Sox2 expression in adult tissues has not
yet been performed. Furthermore, except for neural stem cells
(Suh et al., 2007), genetic fatemapping data to assess the lineage
relationship between fetal and adult Sox2+ cells, aswell as that of
Sox2+ adult cells and their putative progeny, are missing.
In this study, we have developed mouse models to (1) system-
atically evaluate the Sox2 expression pattern, (2) determine the
lineage relationship of Sox2+ cells, and (3) assess the functional
importance of Sox2-expressing cells in adult tissues.
RESULTS
Widespread Sox2 Expression in Adult Epithelial Tissues
In order to systematically evaluate the expression patterns of
Sox2 in adult tissues, we generated Sox2-GFP indicator mice
from ESCs targeted with a previously characterized knockin
construct (Ellis et al., 2004) (Figure 1A). Consistent with other
reports (Avilion et al., 2003; Ellis et al., 2004), we detected strong
GFP expression in blastocysts, neural progenitor cells (NPCs),
and ESC cultures (Figure 1B), indicating that the knockin allele
faithfully reports Sox2 expression in previously documented
Sox2+ cell types.
We next assessed GFP expression in adult tissues of Sox2-
GFP mice by performing immunohistochemistry (IHC) on iso-
lated, paraffin-embedded tissues. In agreement with previous
observations, Sox2-GFP signal was detected in the subventric-
ular zone of the brain, neural retina, trachea, bronchiolar epithe-
lium of the lungs, tongue, and dermal papillae of the hair follicles
(Figure S1 available online and data not shown). In addition, we
identified Sox2-GFP expression in the seminiferous and lens
epithelium and glandular stomach, as well as in squamous
epithelia lining the esophagus, forestomach, anus, and cervix
(Figure 1C and Figures S1 and S3D).
In accordance with the observation that Sox2-GFP expression
is enriched within phenotypically immature basal cells in adult
squamous epithelia, its expression patterns resemble those of
the basal progenitor cell marker p63 in these tissues (Yang
et al., 1998) (Figure 1C and Figures S1 and S3D). Sox2-GFP
signal in the testes was confined to individual and rare cells adja-
cent to the basement membrane, consistent with the previously
defined location of stem cells (Yoshida, 2010) (Figure 1C). Single
Sox2+ cells were also detected in gastric units of the glandular
stomach, composed of the so-called corpus and pylorus com-
partments that have been suggested to contain stem cells
(Bjerknes and Cheng, 2002; Karam and Leblond, 1993) (Fig-
ure 1C). Moreover, we identified rare Sox2+ cells within themitot-
ically active epithelial layer of the lens (Figure S1), which consti-
tutes a stem cell niche (Graw, 2010); in ganglion cells adjacent to
kidney, prostate, uterus, and oral cavity; and in salivary, tracheal,
and cervix-associated glands where it may mark stem or
progenitor cells (Figures S2A and S2B).
No GFP signal was seen in liver, kidney, heart, small intestine,
colon, pancreas, or bone marrow (data not shown). The speci-318 Cell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc.ficity of the Sox2-GFP IHC staining was confirmed by FACS
analysis (Figure S2C) and IHCwith a Sox2-specific antibody (Fig-
ure 1C and Figure S1). While FACS analysis showed GFP+ cells
in all analyzed Sox2-GFP+ tissues, IHC for Sox2 failed to yield
a signal in testes. This may indicate that Sox2 protein levels
are lower in testes compared with those in other tissues or, alter-
natively, that Sox2 mRNA is not translated into protein. In
support of the latter possibility, explanted germline stem cells
have recently been shown to produce Sox2 mRNA, but no
protein (Imamura et al., 2006). The expanded expression domain
of Sox2-GFP signal compared with Sox2 signal across squa-
mous epithelia (Figure 1C) is likely caused by the long half-life
of GFP. Together, our results show that Sox2 exhibits wide-
spread expression in immature-appearing cells of multiple self-
renewing epithelial tissues where it has not been previously
detected in the adult.
Sox2 Marks Bona Fide Adult Stem Cells
To test whether Sox2-expressing cells do in fact contain adult
stem cells, we devised a genetic lineage tracing approach.
In brief, we engineered ESCs to harbor a tamoxifen (TAM)-
inducible Cre allele (CreER-T2) in the endogenous Sox2 locus
(Figures 2A and 2B). Additional targeting of a ROSA26-lox-
STOP-lox (lsl)-EYFP reporter allele (Srinivas et al., 2001) into
these cells and subsequent exposure to the TAM analog
4-OHT gave rise to around 20% EYFP+ cells in treated, but not
in untreated, ESC populations, thus validating the inducibility
and specificity of the system (Figure 2C). Mice were generated
from these ESCs to establish a stable colony of Sox2-CreER;
ROSA26-lsl-EYFP animals for further analysis. Untreated Sox2-
CreER; ROSA26-lsl-EYFP animals and mice treated with solvent
(corn oil) alone showed extremely rare and thus negligible spon-
taneous labeling events in lung, stomach, and brain (data not
shown).
In order to permanently label Sox2-expressing cells and their
progeny in vivo, we initially injected TAM intraperitoneally on 4
consecutive days into a cohort of 3- to 6-week-old Sox2-CreER;
ROSA26-lsl-EYFP animals (Figure 2D). Tissues were isolated
immediately after the treatment (‘‘pulse’’) or at different time
points thereafter (‘‘chase’’). If Sox2 expression marks stem cells,
we would expect to find permanent labeling of both the putative
Sox2+ stem cells and differentiated progeny (Figure 2E). How-
ever, if Sox2+ cells are short-lived progenitors, we would expect
to see transient labeling of cells, which should disappear over
time due to their replenishment by unlabeled stem cells.
We first followed the fate of Sox2-expressing cells in testes
because the differentiation structure of the seminiferous epithe-
lium is relatively simple, with single spermatogonia (As), located
at the basement membrane, continuously giving rise to more
committed chained spermatogonia and ultimately mature sperm
inside the tubules (Yoshida, 2010). Immediately after the pulse,
individual cells were labeled adjacent to the basement mem-
brane, consistent with the observed Sox2-GFP expression
pattern (Figure 2F, top row). After 1 month of chase, small chains
of spermatogonia were EYFP+, and after 3 months of chase,
entire sectors spanning from spermatogonia to mature sperm
were labeled. These results demonstrate that individual Sox2+
cells give rise to more cells of their own, defined as immature
spermatogonia lining the seminiferous epithelium, as well as
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Figure 1. Widespread Sox2-GFP Expression in Epithelial Tissues of Mice
(A) Experimental outline for the generation and analysis of Sox2-GFP reporter mice. IHC, immunohistochemistry; FACS, fluorescence-activated cell sorting.
(B) Sox2-GFP expression in targeted embryonic stem cells (ESCs), the inner cell mass of blastocysts (asterisk marks GFP control blastocyst), and neonatal
neural progenitor cells (NPCs). BF, brightfield.
(C) IHC for GFP, Sox2, and the basal cell marker p63 on paraffin-embedded sections of adult testis, pylorus and corpus of the glandular stomach, esophagus,
forestomach, and anus of wild-type (Sox2-WT) and Sox2-GFPmice. Inserts showmagnifications of Sox2+ cells in longitudinal (top) and cross (bottom) sections of
corpus and pylorus. Asterisk marks unspecific antibody staining of blood vessels. Dashed lines outline gastric units (glandular stomach) or the basement
membrane (testes, esophagus, forestomach, or anus). Original magnifications are as indicated.
See also Figures S1 and S2.
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Sox2+ Epithelial Stem Cellsdifferentiated progeny that continuously produce sperm cells,
thus identifying Sox2+ cells as bona fide stem cells in testes.
We noted that the labeling efficiency in testes was very low
with, on average, only few labeled tubules detected per testis
section.We speculate that this is a consequence of the observed
low transcriptional activity of Sox2 in testes (Figure S2C).CWe next focused on the glandular stomach to follow the fate of
Sox2+ cells. Analysis of Sox2-CreER; ROSA26-lsl-EYFP lineage
tracing mice immediately after the 4 day administration of TAM
showed the appearance of individual dispersed EYFP+ cells as
well as small patches of EYFP+ cells, consistent with the notion
that some rare Sox2+ cells had expanded over the 4 day pulseell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc. 319
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Figure 2. Genetic Lineage Tracing Identifies Sox2+ Stem Cells in Testes, Glandular Stomach, and Lens
(A) Targeting strategy for generating Sox2-CreER ESCs and mice. Restriction sites, Southern blot analysis probes, and expected restriction fragment lengths are
indicated.
(B) Southern blot analyses with 50 and 30 probes, as indicated in (A), to verify correct targeting.
(C) ESCs carrying the Sox2-CreER and ROSA26-lsl-EYFP alleles were analyzed by FACS for EYFP expression 2 weeks after exposure to 4-OHT.
(D) Experimental outline for pulse-chase experiment. Tamoxifen (TAM) was given intraperitoneally on 4 consecutive days to adult Sox2-CreER; ROSA26-lsl-EYFP
mice (‘‘pulse’’). Animals were sacrificed at the indicated time points and tissues were analyzed by FACS and IHC for EYFP. E, embryonic day; wks, weeks; mo,
months.
(E) Possible outcomes of lineage tracing assay. If Sox2-expressing cells are stem cells (SC), they should activate the EYFP reporter upon TAM administration and
give rise to permanently labeled Sox2+ stem cells as well as differentiated progeny (top image). In contrast, Sox2+ progenitors (P) and derivative differentiated
cells (D) would only be transiently labeled (indicated by dashed circle, bottom image).
(F) IHC for EYFP on lineage tracing samples. Note individual cells or small patches of EYFP+ cells immediately after the pulse, which gradually expand over the
subsequent months to span the entire epithelium. Short-term chase reflects 1month (testes) and 2months (stomach and lens), respectively. The long-term chase
periods shown are 6 months for testes and lens, and 15 months for stomach. Original magnifications are as indicated.
See also Figure S3.
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Sox2+ Epithelial Stem Cellsperiod (Figure 2F, middle rows). Importantly, 15–22 months after
the pulse, entire glands were fully labeled in both the corpus and
pylorus, suggesting that Sox2-expressing cells can self-renew320 Cell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc.and give rise to the mature cell types of the glandular stomach
(Figure 2F and Figure S3A). It is worth mentioning that fully
labeled corpus glands were observed less frequently than fully
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Figure 3. Multipotency of Sox2+ Stomach Stem
Cells
(A) Costaining for Sox2-GFP and gastric markers on
pylorus sections. Sox2-GFP+ cells (arrowheads) do not
express differentiated cell markers gastrin (entero-
endocrine cells), MUC5AC (mucus cells), or H-K-ATPase
(parietal cells).
(B) Costaining of lineage tracing sections of Sox2-CreER;
ROSA26-lsl-EYFP mice 14 months after the TAM
pulse with differentiation markers in glandular stomach.
Costaining (arrowhead) was seen between EYFP and
Chromogranin A (enteroendocrine cells) and MUC5AC
(mucus cells) in the pylorus and with H-K-ATPase (parietal
cells) in the corpus-pylorus transition zone.
(C) Colocalization analysis for Sox2 and Lgr5-EGFP in
pylorus. Sox2 (arrowhead) and Lgr5-EGFP (pink) IHC
signals appear to mark different cells in pyloric glands.
(D) Colocalization analysis between proliferation marker
Ki67 and Sox2-GFP. Black arrowheads depict Sox2-
GFP+Ki67 cells, red arrowheads depict Sox2-GFP+Ki67+
cells. Original magnifications are as indicated.
See also Figure S4.
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Sox2+ Epithelial Stem Cellslabeled pyloric glands at all time points and especially soon after
the pulse (1–3months), in agreement with a reported slower turn-
over rate of corpus cells (3–194 days) compared with pyloric
cells (1–60 days) (Barker et al., 2010a).
Similar to the labeling patterns in glandular stomach and
testes, individual EYFP+ cells were detected in the lens epithe-
lium after the TAM pulse (Figure 2F, bottom row). Following the
chase, basal cells remained labeled and also gave rise to mature
lens fibers inside the lens body, consistent with their identity as
stem cells.
Next, we followed the fate of Sox2+ cells in squamous epithelia
of the tongue, esophagus, forestomach, anus, and cervix. Anal-
ysis of these tissues immediately after the 4 day pulse identified
individual EYFP+ cells or patches of labeled cells in the basal and
suprabasal layers of the epithelia, but not in the differentiated
layers, which is in agreement with the observed expression
patterns of Sox2 (Figures S3B and S3D). However, when
analyzing mice 1–3 months after the pulse, we observed
clonal areas of EYFP+ cells stretching from the basal layer to
the keratinized layer. This clonal pattern remained stable at
15–22 months of chase, suggesting that basal Sox2+ cells con-
tain long-term stem cells that maintain these tissues.
Of note, bronchiolar epithelial cells maintained stable EYFP+
clones over several months as well. EYFP+ cells were never
found in the alveoli of the lungs, indicating that Sox2+ cells do
not contain the precursors for alveolar cells under steady stateCell Stem Cell 9, 3conditions (Figure S3C, bottom panels). More-
over, we detected EYFP+ cells within the acini
and ducts of sublingual glands after the pulse,
which remained labeled over the long term,
suggestive of putative stem cells (Lombaert
and Hoffman, 2010) (Figure S3C, top panels).
To exclude the possibility that the observed
labeling patterns were due to marking of tran-
sient postnatal progenitor cells, we repeated
pulse-chase experiments on 6-month-old ani-
mals and analyzed tissue sections 12 monthslater. Consistent with the prior results, we detected fully labeled
EYFP+ tissue clones in the testes, glandular stomach, and squa-
mous epithelia, including tongue, esophagus, forestomach, and
cervix (Figure S3E). However, we noticed a lower frequency of
labeling in older mice compared with that in young animals,
due to a decrease in Sox2+ stem cells, reduced efficiency of
the lineage tracing system with age, or both.
Sox2+ Gastric Stem Cells Are Multipotent
and Self-Renew
In contrast to Sox2+ squamous epithelia, lens, and testes, which
harbor unipotent stem cells, gastric glands of the stomach are
thought to contain multipotent stem cells that can, depending
on the region, produce three or four common cell types through-
out life (Barker et al., 2010a). These are the so-called mucus
cells, parietal cells, enteroendocrine cells, and chief cells, with
the latter cell type only found in the corpus. To further charac-
terize Sox2+ stomach cells and their differentiated progeny, we
first performed double labeling experiments with antibodies
recognizing the major differentiated cell types of the stomach.
This analysis revealed that Sox2-GFP+ cells were negative for
all tested differentiation markers in pylorus and corpus (Fig-
ure 3A and Figure S4A), supporting the notion that they are
uncommitted stem cells. In contrast, analysis of EYFP+ glands
descending from lineage-traced Sox2+ cells 14 months after
the pulse showed costaining of EYFP+ cells with markers of17–329, October 7, 2011 ª2011 Elsevier Inc. 321
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Sox2+ Epithelial Stem Cellsenteroendocrine cells, mucus cells, parietal cells, and chief cells
(Figure 3B and Figure S4B). These data corroborate the conclu-
sion that Sox2+ cells are multipotent stem cells in both the
pylorus and corpus of the glandular stomach. Our observation
that entirely labeled glands were still detectable up to 460 days
after the pulse indicates that Sox2+ stem cells have self-renewal
potential (Figures S3A and S3E).
A previous study has shown that Lgr5+ cells function as multi-
potent stem cells of the pylorus (Barker et al., 2010b), raising the
question of whether there is overlap in the expression patterns of
Sox2 and Lgr5. Lgr5-GFP+ cells were confirmed to be present at
a frequency of three or four cells at the base of each gland, while
we observed either one or two Sox2-GFP+ cells above the base
of each gland (Figure 1C and Figure 3C). Interestingly, IHC for
both Sox2 and GFP on pyloric sections of Lgr5-GFP-ires-CreER
mice showed no apparent overlap in the expression of these two
markers, suggesting that Lgr5 and Sox2 mark different types of
stem cells in the pylorus (Figure 3C). However, we cannot
exclude the existence of double-positive cells expressing low
levels of the respective other marker that was beyond the
threshold for IHC detection.
Colabeling experiments of Sox2-GFP pyloric sections for GFP
and the proliferation marker Ki67 further showed that roughly
50% of the Sox2+ cells are actively cycling (n = 45 Sox2-GFP
nuclei), indicating that half of the Sox2+ cells may be quiescent
under homeostatic conditions (Figure 3D). Analysis of Sox2-
CreER; ROSA26-lsl-EYFP mice receiving only a single dose of
TAM after 1 day and 1 week confirmed our observations that
some Sox2+ cells are cycling and give rise to EYFP+ patches
of cells after 1 week while some Sox2+ cells appear to be slow
cycling and remain as singly labeled EYFP+ cells, respectively
(Figure S4C).
Sox2+ Testis Cells Reconstitute Spermatogenesis
in Germ-Cell-Depleted, Infertile Mice
To confirm that Sox2 expression marks stem cells with an inde-
pendent assay, we tested whether Sox2+ testis cells could
reconstitute spermatogenesis in mice carrying a mutation in
the c-kit gene (designated c-kitW/Wv) that ablates spermatogonial
stem cells, thus rendering animals infertile (Brinster and Zimmer-
mann, 1994).
In order to track donor cells, we crossed Sox2-GFP animals
with ROSA26-lacZ mice, which allowed us to detect trans-
planted donor cells by X-gal staining in recipients (Figure 4A).
FACS analysis of testes cells isolated from 2-week-old male
mice showed that roughly one-third of Sox2-GFP+ cells were
found within the c-kit population, which has previously been
shown to be enriched for testis-repopulating cells (Shinohara
et al., 2000), whereas two-thirds of Sox2-GFP+ cells were found
within the c-kit+ population (Figure S5A). This observation indi-
cates heterogeneity within the Sox2-expressing spermatogonial
cell population and is consistent with a previous study analyzing
c-kit and Oct4-GFP expression in testes (Ko et al., 2009).
Sorted Sox2-GFP+c-kit, Sox2-GFPc-kit, and Sox2-
GFP+c-kit+ cells were then transplanted into the seminiferous
tubules of c-kitW/Wv mice (Figure S5B). When we examined
transplanted testes 4–6 months later, only Sox2-GFP+c-kit
cells gave rise to X-gal+ clones (13/16 testes) that, upon his-
tological analysis, showed repopulation of seminiferous tubules322 Cell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc.and differentiation into mature sperm, whereas both Sox2-
GFP+c-kit+ cells and Sox2-GFPc-kit cells generally failed to
initiate spermatogenesis (0/6 testes and 0/12 testes analyzed,
respectively) (Figures 4B–4D). Our data demonstrate that only
Sox2-GFP+c-kit cells contain testis-repopulating potential
and corroborate the finding that these Sox2-GFP+ spermatogo-
nial cells qualify as authentic stem cells.
In further agreement with our interpretation that Sox2-GFP+
testis cells are stem cells, we discovered that a spermatogonial
stem cell (SSC) line established from unfractionated Sox2-GFP
testis cells expressed Sox2-GFP in nearly all resultant colonies
(Figure 4E and Figure S5C).
Finally, we wondered whether a molecular comparison of
the Sox2-GFP+c-kit+ and Sox2-GFP+c-kit spermatogonial
cells would uncover genes that could explain the exclusive re-
population potential of the latter cell population. To this end,
we sorted individual testis cell populations and subjected ex-
tracted and amplified RNA to array analysis. Indeed, we dis-
covered that well-established spermatogonial stem cell regula-
tors such as PLZF, Oct4, and GFRa1 (Yamada et al., 2006),
which have previously been shown to be important for sper-
matogenesis, were expressed more abundantly in the Sox2-
GFP+c-kit population than in the Sox2-GFP+c-kit+ population
(Figure 4F).
Fetal Sox2+ Cells Give Rise to Adult Sox2+ Stem Cell
Compartments
Given that Sox2 is already expressed and plays important
roles in fetal development, we wondered whether Sox2+ cells
emerging in the embryo are the precursors for the observed
Sox2-expressing tissues in the adult. We first reevaluated
Sox2 expression in E15.5 fetuses by IHC. Consistent with pre-
vious observations, we saw Sox2 signal in the developing brain,
stomach, inner ear, eye, and vibrissae (Figure S6), and in esoph-
agus, trachea, and lungs (data not shown). In addition, we
noticed a Sox2 signal within ganglia and in Schwann cells sur-
rounding nerves, as well as in scattered cells within the epi-
dermis (data not shown).
To determine whether these fetal Sox2+ cells give rise to the
corresponding Sox2+ adult tissue, we injected pregnant females
carrying Sox2-CreER; ROSA26-lsl-EYFP embryos with TAM at
E13.5 or E14.5 and analyzed their tissues as adults (Figure 5A).
Similar to results obtained with adult labeling, we detected
EYFP expression in the forestomach and glandular stomach,
esophagus, tongue, lens, lungs, trachea, and brain (Figure 5B
and data not shown). Moreover, we saw EYFP expression in
rare crypts of the duodenum, which was never seen in adults
and is in agreement with reported Sox2 expression at the
boundary between fetal glandular stomach and duodenum
(Que et al., 2007). In further contrast to adult labeling patterns,
we observed EYFP+ cells in the submandibular gland (Figure 5B).
We also noticed that the labeled stomach samples usually con-
tained clusters of three to ten adjacent gastric units, suggesting
that fetal or early postnatal progenitors had undergone clonal
expansion following their genetic marking. Together, these
results show that early Sox2+ fetal progenitors are the precursors
for Sox2+ adult stem cells and that some tissues (duodenum and
submandibular gland) appear to express Sox2 only transiently
during fetal development.
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Figure 4. Sox2-GFP+ Testis Cells Reconstitute Spermatogenesis in Infertile Mice
(A) Experimental outline. Sox2-GFP animals were crossed with ROSA26-lacZ animals to enable tracking of transplanted donor cells. Sox2-GFP+c-kit cells (1),
Sox2-GFP+c-kit+ cells (2), and Sox2-GFPc-kit cells (3) from the testes of 2-week-old animals were transplanted into the vas deferens of germ-cell-depleted,
infertile c-kitW/Wv recipient mice and testes were analyzed for beta-gal activity after 6 months.
(B) X-gal stain of transplanted c-kitW/Wv testis 6 months after transplantation with the indicated cell populations. Light blue signal (asterisk) reflects background
staining of the interstitium.
(C) Table summarizing repopulation experiments.
(D) Whole-mount X-gal staining (left image) and paraffin sections of repopulated seminiferous tubules counterstained with neutral red (center image). Note the
presence of immature spermatogonia at periphery and mature sperm in center of tubules transplanted with Sox2-GFP+c-kit cells and lack of spermatogenesis
upon transplantation of Sox2-GFPc-kit cells (right image).
(E) Phase contrast and GFP images of a spermatogonial stem cell line derived from Sox2-GFP mice (passage 10).
(F) Scatter plot of gene expression profiles comparing Sox2-GFP+c-kit and Sox2-GFP+c-kit+ testis cells. Green dots depict genes with 2-fold and higher
expression in Sox2-GFP+c-kit+ cells, and red dots depict genes 2-fold and higher expression in Sox2-GFP+c-kit cells. (Pairwise analysis, two-fold change, t test,
p = 0.05, Benjamini and Hochberg correction.) Previously characterized spermatogonial stem cell genes are shown in bold.
See also Figure S5.
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AB
Figure 5. Fetal Sox2+ Progenitors Give Rise to
Adult Sox2+ Stem Cells
(A) Experimental strategy for embryonic lineage tracing.
(B) IHC for EYFP in Sox2-CreER; ROSA26-lsl-EYFP mice
that received one pulse of tamoxifen at E14.5 and were
analyzed after 22 months. Labeled cells were detected in
corpus and pylorus sections of the glandular stomach,
forestomach, esophagus, tongue, lens, ducts (arrow), and
acini (arrowhead) of salivary glands, duodenum, and
tracheal glands. Original magnifications are as indicated.
See also Figure S6.
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Sox2+ Epithelial Stem CellsAblation of Sox2+ Cells Disrupts Tissue Homeostasis
and Causes Lethality
Since Sox2 expression marks stem cells in many epithelial
tissues, we next wished to test if Sox2+ cells are essential for
tissue maintenance and ultimately the viability of mice. To
address this question, we generated Sox2-TK mice from
ESCs in which a truncated thymidine kinase gene (deltaTK)
has been inserted into the endogenous Sox2 locus (Fig-
ures 6A and 6B). Exposure of any Sox2+, dividing cells to the
drug gancyclovir (GCV) is expected to induce cell death.
Indeed, treatment of Sox2-TK ESCs with GCV resulted in
massive apoptosis within 4 days, hence validating the system
(Figure 6C).
To deliver GCV to tissues in vivo, we subcutaneously im-
planted ALZET osmotic pumps into the flanks of Sox2-TK
mice, which systemically release a constant dose of GCV over
2 weeks (Figure 6D). Seven days after implantation, animals
became morbid and died within another week. Treated mice
appeared smaller in size, which may be the result of dehydration
and a failure to resorb food (Figure 6E). Indeed, a body-wide
tissue analysis of morbid mice after 13 days of GCV treatment324 Cell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc.suggested that the development of ulcers of
the stomach and oral mucosa are likely the
causes of death.
The detailed histological analysis of morbid
mice revealed that the Sox2+ layers closest to
the basement membrane were absent in GCV-
treated animals while the stratified layers of
the forestomach, tongue, and esophagus re-
mained unaffected, coinciding with the lack of
Sox2 expression in those cells (Figure 6F). The
absence of immunohistochemical signal for
Sox2 in tissue sections of treated animals con-
firmed that most Sox2+ cells had in fact been
eliminated (Figure 6F). We further detected
severe inflammation and occasionally edema
formation as well as atypical cells in forestom-
ach and tongue (insets in Figure 6F). Because
of these secondary effects, we cannot exclude
the possibility that a destruction of niche cells
in the Sox2-TK model contributed to the
observed loss of epithelia. However, we failed
to observe any obvious phenotypes in the
testes, lungs, and glandular stomach by H&E
staining after 13 days of GCV treatment,
possibly because of a low turnover of Sox2+stem cells in those tissues or inefficient cell ablation. These
data demonstrate that some Sox2+ cells are essential for normal
tissue maintenance and ultimately the survival of mice.
Rescue of Morbidity upon Withdrawal of GCV
Lastly, we wanted to test whether the lethal phenotype caused
by ablation of Sox2+ cells in vivo is reversible. We therefore
administered GCV for only 7 days until mice became morbid
and then surgically removed the pumps (Figure 7A). Histological
analysis of those mice showed a severe disruption of tissue
integrity as was seen before in animals induced for 2 weeks
(data not shown). Notably, discontinuation of GCV treatment re-
sulted in a gradual recovery of animals over the subsequent
weeks, indicating that the morbid phenotype is indeed reversible
(Figure 7B). Sox2 IHC on tissue sections showed residual
Sox2+ cells immediately after GCV treatment, which became
more abundant after 7 days of recovery (Figure S7). Examination
of tissue sections of tongue, esophagus, and forestomach
3 months after withdrawal of GCV showed normal epithelializa-
tion of tissues with intact basal and differentiated cell layers (Fig-
ure 7B and Figure S7). We surmise that residual Sox2+ cells
A B
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Figure 6. Ablation of Sox2+ Cells Disrupts Tissue Homeostasis and Causes Lethality
(A) Targeting strategy to generate Sox2-TK mice. Restriction sites, Southern blot analysis probes, and expected restriction fragment lengths are indicated.
(B) Southern blot analysis to confirm correct integration of Sox2-TK allele in ESCs.
(C) Crystal violet stain of Sox2-TK and control (V6.5) ESCs after 4 days of gancyclovir (GCV) treatment.
(D) Experimental outline. ALZET pumps, releasing a constant dose of GCV over 2 weeks, were implanted into Sox2-TK mice and control Sox2-WT littermates.
Animals were then sacrificed and tissues were analyzed histologically.
(E) Morbid Sox2-TK mouse next to Sox2-WT littermate after 13 days of GCV treatment.
(F) H&E staining of paraffin-embedded sections from tongue, esophagus, and forestomach of GCV-treated Sox2-TKmice shows loss of basal layer (dashed line)
in tongue, esophagus, and forestomach (second column) compared with that in control mice (left column). Note the appearance of atypical cells (arrows) in all
tissues and severe inflammation and edema formation in the forestomach. GCV-treated WT animals remained unaffected (left column). IHC for Sox2 confirmed
almost complete absence of Sox2+ cells in Sox2-TK mice with very rare Sox2+ cells remaining (right column). Original magnifications are as indicated.
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Sox2+ Epithelial Stem Cellsescaped GCV-mediated apoptosis and are responsible for re-
generating the destroyed epithelia. Alternatively, nonablated
suprabasal cells may have repopulated the basal layer to regen-
erate epithelia.CThree months after GCV treatment, the testes of Sox2-TK
mice appeared smaller in size compared with those of GCV-
treated control mice (Figure 7C). Consistent with this finding,
histological analysis showed an increased number of atrophicell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc. 325
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Figure 7. Rescue of Morbidity upon Withdrawal of GCV
(A) Experimental strategy. GCV was given for 7 consecutive days to 3- or 10-week-old mice. Treated Sox2-TK mice and Sox2-WT controls were then allowed to
recover. Tissues were analyzed 7 days (7d) and 3 months (3mo) after removal of GCV pumps.
(B) Histological analysis of Sox2-TK tongue and forestomach after 7 days of GCV treatment followed by 7 days (second column) or 3 months (third column) of
recovery. GCV-treated WT mice and 7-month-old untreated Sox2-TK mice showed no abnormalities in tissue architecture (first and last columns, respectively).
(C) Three months after GCV treatment, testes from Sox2-TK mice exhibited a significant reduction in size compared with those of treated control littermates.
(D) Histological analysis of Sox2-TK testes after 7 days of GCV treatment followed by 7 days or 3 months, respectively, of recovery. After 7 days of recovery, the
seminiferous tubules of Sox2-TK testes showed a mild phenotype with less sperm (second column) compared to those of GCV-treated Sox2-WT animals (left
column). This phenotype was exacerbated after 3monthswhen entire atrophic tubules were seen (third column). No phenotypic abnormalities were seen in testes
of age-matched untreated Sox2-TK mice (right column). Original magnifications are as indicated.
See also Figure S7.
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Sox2+ Epithelial Stem Cellstubules that were completely devoid of spermatogonia and
mature sperm, suggesting that the phenotype of ablating
Sox2+ stem cells manifests later compared with that in forestom-326 Cell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc.ach and tongue (Figure 7D). This delayed phenotype is probably
due to a slower turnover rate of Sox2+ stem cells in testes
compared with forestomach, esophagus, and tongue, and
Cell Stem Cell
Sox2+ Epithelial Stem Cellsdemonstrates that Sox2+ testis cells are essential for continuous
spermatogenesis.
DISCUSSION
In this study, we have identified expression of the stem cell factor
Sox2 in several adult epithelial tissues where it has not previously
been characterized, including the testes, forestomach, glandular
stomach, anus, cervix, esophagus, and lens, as well as glands
associated with oral cavity, trachea, and cervix. Importantly,
we provide unequivocal fate mapping evidence that Sox2+ cells
contain long-term stem cells in some of these tissues. We further
assign a critical requirement for Sox2+ cells in tissue homeo-
stasis by showing that their ablation causes a fatal disruption
of epithelial integrity.
To our knowledge, Sox2 is the only transcriptional regulator
that is commonly expressed between ESCs, fetal progenitors,
and a number of adult stem cells andmay therefore point toward
molecular similarities in the regulation of pluripotent and different
adult stem cells. Our developmental lineage tracing data show
that Sox2+ adult stem cells originate from early Sox2+ epithelial
progenitors in fetal development. These results suggest that
Sox2 expression plays key roles at multiple stages of prenatal
and postnatal development. While it is initially required for the
establishment of pluripotent founder cells within the embryo, it
subsequently controls the formation of fetal ectodermal and
endodermal primordia as well as fetal germ cells and eventually
becomes confined to some derivative adult tissues where it
marks unipotent and multipotent stem cells.
Recent elegant fate mapping studies have found that Lgr5
expression marks stem cells in several epithelial tissues (Barker
et al., 2007; Jakset al., 2008) including thepyloric stomach (Barker
et al., 2010b), raising the question ofwhether the same or different
stemcells are labeledwhen comparedwith Sox2+ cells. Based on
our coexpression results, we conclude that Sox2 expression
labels a different andmore rare population of cells in the glandular
stomach than Lgr5 expression does. Another pronounced differ-
ence between Lgr5+ and Sox2+ stem cells is that Lgr5+ cells are
seen in the intestine and pyloric stomach, whereas Sox2+ cells
are found in both the pylorus and corpus compartment of the adult
glandular stomach, but not in the intestine. A previous study has
identified a rare population of Villin-expressing cells in antral
glands that may coincide with the Sox2-expressing cells
described here. In contrast to our study and the report by Barker
et al. (2010b), however, lineage tracing experiments showed that
these Villin+ cells only give rise to entirely labeled gastric units in
response to interferon treatment. Future studies will be needed
to conclusively establish whether Villin+, Lgr5+, and Sox2+ cells
are different types of stem cells that independently replenish the
stomach or whether these cells are hierarchically related to each
other. The notion of distinct stomach stem cells is reminiscent of
recently identified stem cell markers in the small intestine that
seem to label different cell populations (Barker et al., 2007; Mont-
gomery et al., 2011; Sangiorgi and Capecchi, 2008; Tian et al.,
2011).
In the testis, we detected rare individual Sox2+ cells that may
represent As spermatogonia, which are thought to be the most
primitive cells in testes (Yamada et al., 2006). This interpretation
is supported by our findings that (1) Sox2-GFP+c-kit testis cellsCsuccessfully restore spermatogenesis upon transplantation into
infertile mice, (2) lineage tracing analysis permanently labels
clones containing immature spermatogonia and mature sperm,
(3) ablation of Sox2+ cells results in loss of spermatogenesis,
and (4) derivation of spermatogonial stem cell lines selects for
Sox2-expressing cells. The observation that Sox2 is also ex-
pressed both in c-kit+ testis cells that do not reconstitute sper-
matogenesis and in some transit-amplifying cells of squamous
epithelia, including forestomach, esophagus, tongue, anus, and
cervix, suggests that in these tissues, Sox2 is not exclusively ex-
pressed in stem cells. It is noteworthy that Sox2 expression was
seen in basal cells of squamous epithelia lining inner organs
(anus, cervix, esophagus, forestomach, and tongue), but was
absent from the interfollicular epidermis of the skin, which is
organized in a similar fashion. This may reflect either functional
differences of these epithelia or their distinct developmental
origin despite a remarkably similar structure.
Lastly, we have identified Sox2+ stem cells in the lens epithe-
lium that gives rise to secondary lens fibers throughout adult life,
as well as in ganglia, salivary glands, and glands associated with
trachea and cervix. Additional experiments are required to un-
equivocally test whether Sox2+ cells in those tissues also harbor
stem cell activity.
In summary, our results establish Sox2 as a widespread
marker of pluripotent and many adult stem/progenitor cell types,
and suggest that common target genes and pathways may be
activated that are crucial for maintaining their self-renewal and
differentiation potentials. Given the recent recognition that
Sox2 can act as an oncogene in squamous cell carcinoma of
the lung and esophagus (Bass et al., 2009), it should be inter-
esting to investigate further whether the Sox2-expressing cells,
identified here, can act as tumor-initiating cells, and whether
Sox2 expression itself may be oncogenic in these tissues.
EXPERIMENTAL PROCEDURES
Mice
V6.5 ESCs were targeted with knockin constructs containing CreERT2 (Feil
et al., 1997), puro-delta-TK (Chen and Bradley, 2000), or EGFP (Ellis et al.,
2004) alleles under the control of endogenous Sox2 regulatory elements using
standard protocols. Correct insertion of constructs was verified by Southern
blot, and correctly targeted clones were injected into BDF1 blastocysts and
transferred into pseudopregnant females. Resultant chimeric mice were
bred with 129SvJae mice and germline offspring were bred to establish stable
lines. All animal experiments were approved by the IACUC committee and
conform to the regulatory standards.
TAM Induction
Sox2-CreER; ROSA26-lsl-EYFP ESC clones were treated with one dose of
100 nM 4-OH TAM (Calbiochem), and cells were analyzed by FACS after
2 weeks. Two milligrams TAM (Sigma), dissolved in corn oil, was given daily
to 3- to 6-week-old Sox2-CreER; ROSA26-lsl-EYFP animals on 4 consecutive
days if not otherwise stated. Mice were analyzed by IHC on day 5 (pulse time
point), and at different time points thereafter. Sox2-CreER; ROSA26-lsl-EYFP
littermates injected with corn oil alone were used as controls. Sox2-WT;
ROSA26-lsl-EYFP animals were used as staining control. For lineage tracing
in the embryo, a single pulse of 2 mg TAM plus 1 mg Progesteron was given
to pregnant females at E14.5 and resultant offspring were analyzed at
22 months of age.
Tissue Preparation and IHC
Tissues were harvested, fixed in 10% Formalin or Bouins solution overnight,
and then stored in PBS until further processing. H&E stain and IHC wereell Stem Cell 9, 317–329, October 7, 2011 ª2011 Elsevier Inc. 327
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Sox2+ Epithelial Stem Cellsperformed following standard protocols. Antibodies used were GFP/YFP
(Living colors, JL-8, Clontech); Sox2 (AB5603, Millipore), and p63 (sc-8431,
Santa Cruz), Ki67 (ab15580, Abcam), MUC5AC (ab3649, Abcam); Gastrin
(sc-7783, Santa Cruz); H-K-ATPASE (D032-3H, MBL), and Chromogranin A
(ab15160, Abcam).
GCV Treatment
Cultured Sox2-TK ESC clones were treatedwith 2 mMGCV (Cytovene, Roche).
For in vivo treatments, GCV was dissolved in 0.9% saline and filled into ALZET
osmotic pumps. Seven-day or fourteen-day pumps were used to release
a constant dose of 2 mg/day. Mice were anesthetized and pumps were in-
serted subcutaneously. For recovery experiments, 7 day GCV pumps were
inserted subcutaneously and surgically removed after 7 days.
Spermatogonial Cell Transplantation
Testes from 10–20 Sox2-GFP; ROSA26-lacZ+ donor mice were dissected at
the age of 2 weeks to harvest single cell suspensions. Sox2-GFP+c-kit,
Sox2-GFP+c-kit+, and Sox2-GFPc-kit populations were sorted by FACS
and transplanted into the vas deferens of germ-cell-depleted, infertile
c-kitW/Wv recipient mice. Briefly, 25,000 cells were transplanted per testis.
Leuprolide (Sigma) (0.77 mg/g bodyweight) was injected right after transplan-
tation to support engraftment. Transplanted mice were analyzed 6 months
after transplantation for repopulation of seminiferous tubules by X-gal staining
and by histological examination.
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